Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
about
Acamprosate for alcohol dependenceOpioid antagonists for alcohol dependenceAcamprosate: a prototypic neuromodulator in the treatment of alcohol dependenceChronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapseAn evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) studyGlutamatergic substrates of drug addiction and alcoholismOptimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?Alcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinenceTargeting central melanocortin receptors: a promising novel approach for treating alcohol abuse disordersImproving clinical outcomes for naltrexone as a management of problem alcohol useRecent advances in the discovery and preclinical testing of novel compounds for the prevention and/or treatment of alcohol use disorders.The clinical pharmacology of acamprosate.Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J miceUpdate on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.Reduced alcohol intake and reward associated with impaired endocannabinoid signaling in mice with a deletion of the glutamate transporter GLAST.Review of biological mechanisms and pharmacological treatments of comorbid PTSD and substance use disorder.The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.Relaxin-3/RXFP3 system regulates alcohol-seeking.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.Packages of care for alcohol use disorders in low- and middle-income countries.The Impact of Mobile Apps on Alcohol Use Disorder: A Systematic Review ProtocolFirst-line medications for alcohol use disorders among public drug plan beneficiaries in Ontario.Potent inhibition of alcohol self-administration in alcohol-preferring rats by a κ-opioid receptor antagonistUnderstanding attitudes towards use of medication in substance abuse treatment: A multilevel approach.Placebo group improvement in trials of pharmacotherapies for alcohol use disorders: a multivariate meta-analysis examining change over time.Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent ratsDrug effects on multiple and concurrent schedules of ethanol- and food-maintained behaviour: context-dependent selectivity.Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues.Cabergoline decreases alcohol drinking and seeking behaviors via glial cell line-derived neurotrophic factor.Alcohol and the human brain: a systematic review of different neuroimaging methods.Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients: Design and Implementation.Pharmacoprophylaxis of alcohol dependence: Review and update Part II: EfficacyAlcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors.Synthesis and pharmacological evaluation of 6-naltrexamine analogs for alcohol cessation.A genetic determinant of the striatal dopamine response to alcohol in menPharmacogenetics of alcohol and alcohol dependence treatmentThe neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.Acamprosate-induced Extrapyramidal Symptoms in an Elderly Patient with Alcohol Dependence.A mixed non-homogeneous hidden Markov model for categorical data, with application to alcohol consumption.Comparison of healthcare utilization among patients treated with alcoholism medications.
P2860
Q24235594-8D6F0380-D168-4944-9ED2-2287711D87D7Q24235797-11198714-AEEF-4D08-A180-48E8C62915BFQ24595863-ED34CE48-B90C-47B5-A4AA-C6404512E65BQ24633835-3ACA5547-5328-49D2-8B0D-010C96DD22A1Q24645469-715B8132-CAAB-4E70-8FCE-8CD31D6A7006Q24648924-360AC952-F8A8-4BF4-A68F-1D0A9EF48A73Q26769622-3AF1A6E6-578E-425A-9EA9-5180BA1CD544Q26801196-FA1C8532-901A-4EE1-8E3F-0F2CC7D1C421Q27008813-32A321DC-7952-40FF-82B3-31D6A593CFF5Q27021406-D57E1805-5E40-4C3E-9BE8-53FFD0A3D188Q27024533-AAC2C66D-6E7C-45B9-92B7-85E0CDE8AACBQ27687874-6A02D1B1-3EB2-496F-B559-B42D98E758EBQ28386651-11E25F61-793F-48A6-9264-F0D31D86E20CQ30440516-2C684565-73EB-4AAE-B2FE-A5A01AF464A8Q30451627-F1520EEE-0E93-472F-8C52-6CBFFECBC1A1Q30458749-A534C770-528A-4B39-ABC3-B2346B635FC8Q30490602-A9EEE0C9-70A5-417C-8185-8D427D01F808Q30560386-14802AE4-0313-4970-8E8B-B1E1902B4367Q33319816-EF7A5887-F060-4A82-9075-17DDA4648557Q33512908-C5A07E2E-B6EF-4CB4-8A52-4DA26D305E9CQ33576100-AD25B2D4-8C70-4E9F-976F-E3E66EF2C89AQ33675540-1EC6D53A-F58C-49F6-AC20-FFD241B0106CQ33750830-4CA429A7-FF67-43D6-A171-B4AB334AF81BQ33791771-7CF6919B-4A01-4A8A-B143-4E51067D43ACQ33828162-DAE7FE16-6B7E-4FE6-9FA9-708748E788EFQ33828177-31922E2E-AB3B-46BA-A24A-4AFBD66D3367Q33929790-7CF3EBCB-9049-4A1D-A200-AF913F5F78B1Q33940215-758B498A-7B76-4DCC-AD91-C8BBB2C38024Q33954437-183760EC-B93F-407B-AF6F-6996D309A90DQ33967245-1489F259-886C-4B6A-90FD-5AF8D2FC53BEQ33967666-E150482B-0D29-422C-A40C-E93BD1EC07B4Q33974746-74BE4FD1-ACC3-46EA-A1A6-F68F2479A19EQ34018001-A23989F5-B67A-42C7-858B-CBAEBE7A0807Q34043568-E43589C0-C54B-40CA-9C3F-01173D95362EQ34077390-7B6EC652-B659-46A7-9A98-8C5454BBF339Q34081709-B78F25D8-FEDA-4525-955B-76DD188930FAQ34088940-D1606FC6-7975-4F99-9573-39C2C6B5A9E9Q34129873-3C048D68-30B0-4F0D-B290-911DFA081FACQ34149677-DC6CB48C-E956-42D2-8E23-DE0A97B11D3DQ34162896-469681EE-1B7F-4C1C-8AA6-1CE7227C09AB
P2860
Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Efficacy and safety of naltrex ...... pendence: a systematic review.
@ast
Efficacy and safety of naltrex ...... pendence: a systematic review.
@en
Efficacy and safety of naltrex ...... pendence: a systematic review.
@nl
type
label
Efficacy and safety of naltrex ...... pendence: a systematic review.
@ast
Efficacy and safety of naltrex ...... pendence: a systematic review.
@en
Efficacy and safety of naltrex ...... pendence: a systematic review.
@nl
prefLabel
Efficacy and safety of naltrex ...... pendence: a systematic review.
@ast
Efficacy and safety of naltrex ...... pendence: a systematic review.
@en
Efficacy and safety of naltrex ...... pendence: a systematic review.
@nl
P2093
P2860
P1433
P1476
Efficacy and safety of naltrex ...... pendence: a systematic review.
@en
P2093
Carmen Bouza
José María Amate
Magro Angeles
P2860
P304
P356
10.1111/J.1360-0443.2004.00763.X
P407
P577
2004-07-01T00:00:00Z